Evidence map›Paper›PMID 28371548›Full record

ArticleThe FEBS journal2017

Characterization of the first naturally thermostable terpene synthases and development of strategies to improve thermostability in this family of enzymes.

Matthew Q Styles, Edward A Nesbitt, Scott Marr, Marc Hutchby, David J Leak

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The FEBS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Optimization of IspSApplied and environmental microbiology · 2023
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew Q StylesDepartment of Biology and Biochemistry, University of Bath, UK.ORCID 0000-0002-5737-1174
Edward A NesbittDepartment of Biology and Biochemistry, University of Bath, UK.
Scott MarrDepartment of Biology and Biochemistry, University of Bath, UK.
Marc HutchbyDepartment of Chemistry, University of Bath, UK.
David J LeakDepartment of Biology and Biochemistry, University of Bath, UK.
University of Bath · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The terpenoid family of natural products is being targeted for heterologous microbial production as a cheaper and more reliable alternative to extraction from plants. The key enzyme responsible for diversification of terpene structure is the class-I terpene synthase (TS), and these often require engineering to improve properties such as thermostability, robustness and catalytic activity before they are suitable for industrial use. Improving thermostability typically relies on screening a large number of mutants, as there are no naturally thermostable TSs described upon which to base rational design decisions. We have characterized the first examples of natural TSs exhibiting thermostability, which catalyse the formation of the sesquiterpene τ-muurolol at temperatures up to 78 °C. We also report an enzyme with a k DATABASE: Model data are available in the PMDB database under the accession number PM0080780.

Indexed as

Alkyl and Aryl TransferasesChloroflexiEscherichia coliHot TemperatureKineticsModels, ChemicalModels, MolecularPolyisoprenyl PhosphatesProtein ConformationProtein StabilityRecombinant ProteinsSesquiterpenesStructure-Activity RelationshipTerpenesAlkyl and Aryl Transferasesfarnesyl pyrophosphatePolyisoprenyl PhosphatesRecombinant ProteinsSesquiterpenesTerpenesterpene synthasekineticsstructural modelterpenoidthermophilethermostability

Identifiers

PMID28371548
PMCPMC6849719
OpenAlexW2604438798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.